Progress in defining the nature of T cell receptors for antigen has been slow and many conflicting results have been reported (reviewed in reference 1). Recently more success has been achieved by developing monoclonal antibodies, directed against T cell clones, that show unique specificities for the clones (2-4). In this study we have utilized a similar approach and have screened monoclonal antibodies made against cells from a human T cell leukemia for idiotypelike specificity. Two such monoclonal antibodies were found that reacted with the same membrane molecule; one showed absolute specificity for the immunizing cells, the other also reacted with a small population of normal T cells.
cells in T cell lymphomas, one sample of adult T cell leukemia, and seven samples of cutaneous T cell lymphoma (five with Mycosis Fungoides and 2 with Sezary Syndrome). Some of the malignant cell samples were the generous gift of Dr. Barton Haynes.
Cell surface molecules were radioiodinated using the lactoperoxidase technique. Immunoprecipitation was performed using a modification of the technique of Allison et al. (2) . The immunoprecipitates were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described (2) . Two-dimensional gel electrophoresis was performed using a modification of the technique of O'Farrell (6) .
Experiments to detect modulation of surface antigens were performed as previously described (6) . Enrichment of the population of normal T cells reactive with the monoclonal $511 was obtained using the indirect rosetting technique of Mayer et al. (7) .
Results
Screening of Mo~oclonal Antibodies. Six fusion experiments were performed, yielding 610 viable hybrids. After initial screening by immunofluorescence and flow cytometry, 28 were found to show some specificity for the immunizing cells. Further screening with T cells and non-T cells yielded two antibodies that appeared to react primarily with the immunogen. These two hybrids, called S 160 and $511, were cloned and the supernatants of clone cultures (S 160-1 and $511-2) were used for further study by indirect immunofluorescence. One lot of supernatant from each clone was determined to be saturating on the immunizing cells in indirect fluorescence studies when diluted to 1:20, however, undiluted supernatants were always used. Ouchterlony analysis of the clone culture supernatants revealed that S160-1 was an IgG~k antibody and $511-2 was IgG2bk antibody.
The percentage of positive cells reacting with the monoclonals was always within 5% of the visual leukocyte differential that showed "-85% of the mononuclear cells in the leukopheresis to be leukemic cells. Analysis by flow cytometry consistently revealed a population of nonreactive cells that correlated with nonmalignant cells observed by visual immunofluorescence that were present in the sample. Table I shows some of the results for the two monoclonals with a wide variety of cell types including other T cell leukemias and long term T cell lines. These were all negative with the exception of leukemia S cells, which were the immunizing antigen. The S leukemia was a Sezary type T cell and negative for the human T cell leukemia virus (HTLV). Other samples of Sezary T cells plus two cells known to be positive for HTLV, HUT 102 and the patient with adult T cell leukemia, were negative with these antibodies.
$511-2 showed a definite reactivity with a small population of normal T cells, which was not seen with S160-1. 15 different preparations of normal T cells were studied by flow cytometry and the range of positivity for $511-2 was 0.8-2.7%, with a mean value of 1.6%. Table I ; the reaction with S160 remained negative. Modulation Experiments. Table II 
TABLE II

Modulation of the Antigen Detected by Monoclonal Antibodies S-160 and S-511 by Leu-4(T3) Antibody
Antibody used to induce modulation
Percentage of positive cells after restaining with:
Leu-4 S-160 S-511 Leu-1 T-11 % Leu-4  11  13  15  93  87  S-160  37  23  20  93  92  S-511  68  52  46  92  93 in the reverse direction with the leukemia antibodies show only a partial effect on the Leu-4 antibody reaction. Discussion The two monoclonal antibodies described above clearly show idiotypelike specificity for a membrane component of the leukemic T cells used for immunization. Both antibodies failed to react with the non-malignant cells of the S leukemia, any other leukemic T cells, T cell lines, B cells, or any other cell type tested. Antibody S 160-1 also failed to react with normal T cells. Antibody $511-2, however, did react with a small population of normal T cells, "~2%. The latter could be markedly enriched with the monoclonal antibody making it easier to demonstrate the specific reactivity. Immune precipitation of labeled membrane components of the leukemic T cells followed by gel separation showed that both monocional antibodies brought down very similar molecules. In the unreduced state they showed bands with the same mobility of --~80 kdaltons. On reduction two bands were observed with mobility of "~43 and ~38 kdaltons. The larger 43-kdalton band was always fainter than the 38-kdalton band, but both clearly arose from the 80-kdalton protein after reduction. The exact reason for the difference in intensity of the two bands is not apparent. It may be a result of differential membrane labeling with 12~'I.
Two-dimensional gels showed some further separation of each of the bands. The 38-kdalton band gave a series of spots resembling those of multiply glycosylated derivatives. Thus each monocional antibody recognized a similar disulfide-linked protein that separated on reduction into two nonidentical polypeptide chains. Further evidence that these antibodies recognized the same component was obtained from serial precipitation studies; initial precipitation with one antibody removed antigen for the other. Also, in the immunofluorescence studies each antibody blocked the other.
Although no direct evidence was obtained that these antibodies recognized a type of T cell receptor on these leukemic T cells, considerable indirect evidence strongly suggests that this is indeed the case. The molecules described above are similar to those described both in the mouse and the human for cytotoxic T cell clones in which inhibition of the specific activity with the antibody was observed (3, 4). Minor differences were observed, especially with the previous human study (3) in which the reduced bands were reported as larger. In each case however, two disulfide-linked polypeptide chains were involved. Allison and coworkers (2) have emphasized the rarity of other molecules on T cell membranes that consist of disulfide-linked polypeptides. In addition, Leu-4 (T3) antibodies were found to modulate the receptor for both antibodies used in the present study. The close relationship of the T3 antigen and various T cell receptors has been emphasized (3, 8) . Perhaps the strongest evidence for a relationship to T cell receptors stems from the private idiotypelike antigen reacting with the one antibody and the slightly public antigen among T cells reacting with the other, even though both antigens are present on the same protein molecules. This strongly suggests an antibodylike system.
The relationship between the two polypeptide chains observed and the two antigenic sites detected by the monoclonal antibodies remains to be determined. The one antigenic site appears to involve a variable region with a private "idiotype." The other antigenic site, found on some normal T cells, could also derive from variable regions and represent a cross-reactive "idiotype" or a framework antigen. However, it is also possible that this represents a constant region antigen that is characteristic of a small percentage of T cells with a specific function.
A distinct advantage of the use of human leukemic T cells for the study of T cell receptors for antigen is the large amount of material available for the isolation and characterization of the receptors. Sufficient progress has been made, especially with the specific receptors on II-2-dependent T cell clones mentioned above, to enable this work to proceed successfully with leukemic cells and T cell lines even when no biological activity is apparent. In some instances however, T cell leukemias have been shown to have specific recognition properties and these will be all the more useful. Experiments parallel to those in the present studies are currently underway in our laboratory with one such T cell leukemia that shows specific stimulation by defined alloantigens. These antiidiotypic antibodies also may prove useful in the future therapy of these leukemias.
Summary
Two monoclonal antibodies were obtained that showed unique specificities for the leukemic T cells used for immunization. One antibody, S160, was totally specific for the antigen. The other antibody, $511, also reacted with a small population of normal T cells. This was made especially evident by concentrating these normal T cells with the antibody. Considerable evidence was obtained that both antibodies reacted with the same membrane molecules. In the unreduced state a major component of -~80 kdaltons was observed; after reduction this split into two components of "--43 and "-'38 kdaltons. The reaction of the two antibodies with different antigenic sites on the same molecule, one representing a private site and the other a more cross-reactive site, strongly suggests an antibodylike molecule, but composed of polypeptide chains differing from immunoglobulins.
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